These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33336890)

  • 1. Pentafluoro-3-hydroxy-pent-2-en-1-ones Potently Inhibit FNT-Type Lactate Transporters from all Five Human-Pathogenic Plasmodium Species.
    Walloch P; Hansen C; Priegann T; Schade D; Beitz E
    ChemMedChem; 2021 Apr; 16(8):1283-1289. PubMed ID: 33336890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The
    Davies H; Bergmann B; Walloch P; Nerlich C; Hansen C; Wittlin S; Spielmann T; Treeck M; Beitz E
    Antimicrob Agents Chemother; 2023 Aug; 67(8):e0035623. PubMed ID: 37428074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and Development of Inhibitors of the Plasmodial FNT-Type Lactate Transporter as Novel Antimalarials.
    Nerlich C; Epalle NH; Seick P; Beitz E
    Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832972
    [No Abstract]   [Full Text] [Related]  

  • 4. Structural characterization of the Plasmodium falciparum lactate transporter PfFNT alone and in complex with antimalarial compound MMV007839 reveals its inhibition mechanism.
    Peng X; Wang N; Zhu A; Xu H; Li J; Zhou Y; Wang C; Xiao Q; Guo L; Liu F; Jia ZJ; Duan H; Hu J; Yuan W; Geng J; Yan C; Jiang X; Deng D
    PLoS Biol; 2021 Sep; 19(9):e3001386. PubMed ID: 34499638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of Scaffold Nitrogen Atoms Renders Inhibitors of the Malarial l-Lactate Transporter, PfFNT, Effective against the Gly107Ser Resistance Mutation.
    Walloch P; Henke B; Häuer S; Bergmann B; Spielmann T; Beitz E
    J Med Chem; 2020 Sep; 63(17):9731-9741. PubMed ID: 32816478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence Cross-Correlation Spectroscopy Yields True Affinity and Binding Kinetics of
    Jakobowska I; Becker F; Minguzzi S; Hansen K; Henke B; Epalle NH; Beitz E; Hannus S
    Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Malaria Parasite's Lactate Transporter PfFNT Is the Target of Antiplasmodial Compounds Identified in Whole Cell Phenotypic Screens.
    Hapuarachchi SV; Cobbold SA; Shafik SH; Dennis AS; McConville MJ; Martin RE; Kirk K; Lehane AM
    PLoS Pathog; 2017 Feb; 13(2):e1006180. PubMed ID: 28178359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate-analogous inhibitors exert antimalarial action by targeting the Plasmodium lactate transporter PfFNT at nanomolar scale.
    Golldack A; Henke B; Bergmann B; Wiechert M; Erler H; Blancke Soares A; Spielmann T; Beitz E
    PLoS Pathog; 2017 Feb; 13(2):e1006172. PubMed ID: 28178358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intracellular parasite
    Erler H; Ren B; Gupta N; Beitz E
    J Biol Chem; 2018 Nov; 293(45):17622-17630. PubMed ID: 30237165
    [No Abstract]   [Full Text] [Related]  

  • 10. Identity of a Plasmodium lactate/H(+) symporter structurally unrelated to human transporters.
    Wu B; Rambow J; Bock S; Holm-Bertelsen J; Wiechert M; Soares AB; Spielmann T; Beitz E
    Nat Commun; 2015 Feb; 6():6284. PubMed ID: 25669138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cation ATPase (ATP4) Orthologue Replacement in the Malaria Parasite Plasmodium knowlesi Reveals Species-Specific Responses to ATP4-Targeting Drugs.
    Mohring F; van Schalkwyk DA; Henrici RC; Blasco B; Leroy D; Sutherland CJ; Moon RW
    mBio; 2022 Oct; 13(5):e0117822. PubMed ID: 36190127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formate-nitrite transporters carrying nonprotonatable amide amino acids instead of a central histidine maintain pH-dependent transport.
    Helmstetter F; Arnold P; Höger B; Petersen LM; Beitz E
    J Biol Chem; 2019 Jan; 294(2):623-631. PubMed ID: 30455351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy and limit of detection of ten malaria parasite lactate dehydrogenase-based rapid tests for
    Tan AF; Sakam SSB; Rajahram GS; William T; Abd Rachman Isnadi MF; Daim S; Barber BE; Kho S; Sutherland CJ; Anstey NM; Yerlikaya S; van Schalkwyk DA; Grigg MJ
    Front Cell Infect Microbiol; 2022; 12():1023219. PubMed ID: 36325471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why is the Plasmodium falciparum hexose transporter a promising new drug target?
    Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S
    Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level cell-free production of the malarial lactate transporter PfFNT as a basis for crystallization trials and directional transport studies.
    Holm-Bertelsen J; Bock S; Helmstetter F; Beitz E
    Protein Expr Purif; 2016 Oct; 126():109-114. PubMed ID: 27345711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analyses of the malaria parasite aminoacyl-tRNA synthetases provide new avenues for antimalarial drug discovery.
    Chhibber-Goel J; Yogavel M; Sharma A
    Protein Sci; 2021 Sep; 30(9):1793-1803. PubMed ID: 34184352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
    Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
    ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of benzhydryl-based antiplasmodial agents possessing Plasmodium falciparum chloroquine resistance transporter (PfCRT) inhibitory activity.
    Relitti N; Federico S; Pozzetti L; Butini S; Lamponi S; Taramelli D; D'Alessandro S; Martin RE; Shafik SH; Summers RL; Babij SK; Habluetzel A; Tapanelli S; Caldelari R; Gemma S; Campiani G
    Eur J Med Chem; 2021 Apr; 215():113227. PubMed ID: 33601312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.